Next Generation Sequencing Market And its Growth prospect in the Near Future

1
Next Generation Sequencing Market
Publication Month Mar 2018 Report Code
TIPHE100000820 No. of Pages 150 Category
Biotechnology Status Published
Next Generation Sequencing Market to 2025 -
Global Analysis and Forecasts by Product
(Platforms, Services, Consumables) Service
(Genome Sequencing, Exome Sequencing,
Re-sequencing Targeted Sequencing, Other
Sequencing Technologies) Application
(Diagnostics, Drug Discovery, Precision Medicine,
Other Applications) End User (Academic
Research Institutes, Pharmaceutical
Biotechnology Companies, Hospitals Clinics,
Other End Users)
E-Mail  sales_at_theinsightpartners.com
2
Next Generation Sequencing Market
Publication Month Mar 2018 Report Code
TIPHE100000820 No. of Pages 150 Category
Biotechnology Status Published
Introduction The next generation sequencing
market is estimated to grow at a CAGR of 21.1
during the forecast period from 2018 to 2025. The
next generation sequencing market is estimated to
reach US 26,501.25 Mn by 2025.Next generation
sequencing (NGS) is the technology which is used
to align millions of small fragments of DNA
simultaneously that are capable of processing
multiple DNA sequences in parallel. The arrival
of rapid DNA sequencing methods has significantly
enhanced biological and medical research and
discovery. The demand for next generation
sequencing technology has been increasing widely
due to the rise in genetic tests. The
availability of next generation sequencing at low
cost, technological advancements and high
prevalence of cancer cases during the previous
years. Also, the companies operating the next
generation sequencing market have been investing
substantial time and amount in research and
development activities, through which better
technologies can be introduced in the market.
E-Mail  sales_at_theinsightpartners.com
3
Next Generation Sequencing Market
Publication Month Mar 2018 Report Code
TIPHE100000820 No. of Pages 150 Category
Biotechnology Status Published
In our study, we have segmented the next
generation sequencing market by product, service,
application and end-users. The products
considered in the study are platform, services,
and consumables. The platform segment is further
segmented as Hiseq, Miseq, Solid, ION Torrent,
Pacbio Rs II Sequel Systems. The sub-segment of
services is further divided as sequencing
services and data management analysis services.
Consumables is further bifurcated as sample
preparation consumables, library preparation
target enrichment kits reagents, and quality
control kits reagents. The services segment is
classified as genome sequencing. Exome
sequencing, resequencing targeted sequencing,
and other services. The applications of next
generation sequencing covered in the report
include, diagnostics, drug discovery, precision
medicine, and others. The end-users of next
generation sequencing is classified as academic
research institutes, pharmaceutical
biotechnology companies, hospitals clinics, and
others. Geographically, the market for next
generation sequencing is categorized as North
America, Europe, Asia Pacific (APC), Middle East
and Africa (MEA) and South and Central America
(SCAM).The next generation sequencing market
is witnessing a healthy growth rate during the
previous years and is expected to witness similar
trend in the coming years. The companies
operating in the market of next generation
sequencing provide their products and services
for applications such as drug discovery,
diagnosis, and precision medicine. With constant
RD activities, the companies have been focusing
towards developing advanced techniques in next
generation sequencing that can be useful for end
users such as hospitals clinics, academic
institutions, etc. Various players have been
upgrading their product portfolio by applying for
approvals. With expansion activities, companies
are focusing towards strengthening their customer
base by providing services to varied applications.
E-Mail  sales_at_theinsightpartners.com
4
Next Generation Sequencing Market
Publication Month Mar 2018 Report Code
TIPHE100000820 No. of Pages 150 Category
Biotechnology Status Published
The global next generation sequencing market is a
matured market in the developing countries as
well as developing economies worldwide. The
necessity of genetic analysis is constantly
increasing in recent days due to the reliable and
accurate results being offered by the technique.
The demand for next generation sequencing is
experienced mostly from academic institutions
followed by hospitals clinics. Among the
applications, the demand for next generation
sequencing is significantly high in diagnostics,
drug discovery, followed by precision medicine.
Furthermore, advancements in sequencing
technologies and declining cost of sequencing is
expected to be a driving factor for the next
generation market.Modification and automation
of this process continued to increase sequencing
data and time reduction. Thereby allowing
researchers to reach major milestones in the
Human Genome Project. NGS makes sequence based
gene expression analysis a "digital? alternative
to analog techniques. It also aids in quantifying
RNA expression with the breadth of a microarray
and the resolution of qPCR. Advancement in genome
sequencing has made the sequencing easy and
accurate. These technological advancement are
likely to grow the market in near future.Cancer
can be cured if diagnosed and treated at an
initial stage. Cancer sequencing using
next-generation sequencing (NGS) methods provides
more information. Additionally, NGS also aids in
diagnostics and treatment of cancer. In recent
years, the cases of cancer has been increasing
tremendously and the trend is anticipated to
remain the same in the upcoming years. Due to
preference of better technologies for detection
of fatal disease, the demand for next generation
sequencing is anticipated to witness constant
growth in the upcoming years.
Get a PDF Sample Copy
E-Mail  sales_at_theinsightpartners.com
5
Next Generation Sequencing Market
Publication Month Mar 2018 Report Code
TIPHE100000820 No. of Pages 150 Category
Biotechnology Status Published

• The List of Companies
• 1. Illumina, Inc.
• 2. Thermo Fisher Scientific, Inc.
• 3. Qiagen N.V.
• 4. Beijing Genomics Institute
• 5. Perkinelmer, Inc.
• 6. F. Hoffmann-La Roche AG
• 7. Agilent Technologies
• 8. Eurofins Scientific
• 9. Oxford Nanopore Technologies, Ltd.
• 10. Macrogen, Inc.
• Inquire more _at_ https//www.theinsightpartners.com/
  inquiry/TIPHE100000820

E-Mail  sales_at_theinsightpartners.com